Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2015, to approve the audited stand-alone and consolidated financial results for the quarter / year ended on March 31, 2015 and to ... Moneycontrol.com, 1 day ago
Cadila Healthcare: Outcome of board meeting - Moneycontrol.com, 2 weeks ago
The vaccine R&D subsidiary of Zydus Cadila,Etna Biotech today announced it has donated 240,000 dollar for a collaborative programme with the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH) ...NetIndia123.com, 5 days ago Zydus' arm Etna Biotech to donate $240,000 to National Institutes of Health Indian-Commodity, 5 days ago Zydus Group to Donate USD 240,000 to The National Institutes of Health, USA for Advancing Leishmaniasis Research Wall Street Business Network, 5 days ago
Cadila Healthcare is seeking shareholders' nod for raising upto Rs 10,000 crore from the capital markets by issuing equity shares, including instruments such as convertible bonds/debentures through qualified institutional placement, to capitalise on ...Indian-Commodity, 2 weeks ago Cadila to Seek Investors' Nod to Raise up to Rs 10,000 Cr NDTV Profit, 2 weeks ago Cadila to seek shareholders' nod to raise up to Rs 10,000 crore Economic Times, 2 weeks ago
Cadila Healthcare has purchased 50 percent shares of Zydus BSV Pharma Private Limited (Zydus BSV) from Bharat Serums and Vaccines Limited and now Zydus BSV has become 100 percent subsidiary of Cadila Healthcare Limited.Money Control, 1 month ago Cadila Healthcare in the pink of health Business Standard, 1 month ago
Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...
Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...Arihant Capital, 5 days ago
Cadila Healthcare revealed that its US subsidiary Etna Biotech will collaborate with the US national Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to develop a vaccine against visceral leishmaniasis, The Economic ...FirstWord Pharma, 4 days ago Zydus ties up with US-based R&D to develop vaccine Hindu Business Line, 5 days ago Zydus ties up with US-based RD centre to develop vaccine Moneycontrol.com, 5 days ago
More from: , Daily Excelsior.com...and 3 other sources
1006 GMT [Dow Jones] Indian generic drug makers Cadila Healthcare (532321.BY) and Dr. Reddy's Laboratories (500124.BY) are up 0.4% and 1.5% respectively after IMS Health flags strong January sales for both. The market research firm says three-month ...iMarketReports, 1 month ago Aurobindo Pharma Sells Australian Subsidiary To Eris Pharma Deal Curry, 2 weeks ago Pharmaceutical Newsletter - April 06 to 10, 2015 India Infoline, 2 weeks ago
CADILA HEALTHCARE : Patent Issued for Topical Pharmaceutical Compositions Containing Nanodroplets for the Treatment Psoriasis
By a News Reporter-Staff News Editor at Pharma Business Week -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Roy, Sunilendu Bhushan (Ahmedabad, IN); Kothari, Jay Shantilal (Ahmedabad, IN); Sheikh, Shafiq ...4 Traders, 2 weeks ago CADILA HEALTHCARE : Patent Application Titled "Pharmaceutical Compositions of Sodium Picosulfate, Magnesium Oxide and Citric Acid" Published Online 4 Traders, 1 month ago CADILA HEALTHCARE : Researchers Submit Patent Application, "Method for Treatment of Pain and Inflammation", for Approval 4 Traders, 1 month ago
ET INTELLIGENCE GROUP: Times couldn't have been better for the Indian pharma sector, or so the stock market believes. Anything that is remotely pharma has appreciated in value in the past few years. About 45% of listed pharma stocks have more than ...Economic Times, 1 week ago High-flying pharma sector may be in need of a health check Economic Times, 1 week ago
Related to : Cipla Ltd,Lupin Ltd,Sun Pharmaceuticals Industries Ltd Cipla Ltd BSE 06 Apr 15 | 02:17 PM 729.40 19.95 (2.81%) NSE 06 Apr 15 | 02:10 PM 731.20 21.6 (3.04%) Shares of pharmaceutical companies continued at their upward ...Smart Investor, 3 weeks ago Pharma shares rally continue; BSE Healthcare index zooms over 500 points Smart Investor, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!